Global Gelfoam Market Insights Forecasts to 2033

• The Global Gelfoam Market Size was estimated at USD 1.04 Billion in 2023
• The Market Size is Expected to Grow at a CAGR of around 8.68% from 2023 to 2033
• The Worldwide Global Gelfoam Market Size is Expected to Reach USD 2.39 Billion by 2033
• Asia Pacific is expected to grow the fastest during the forecast period.

The Global Gelfoam Market Size is accounted to exceed USD 2.39 billion by 2033, growing at a CAGR of 8.68% from 2023 to 2033. The gelfoam market drivers are upwardly trending surgical procedures and a focus on patient safety. Key players, namely Johnson & Johnson and Medtronic, are at the forefront in providing hemostatic solutions. The demand is burgeoning in healthcare sectors around the globe, particularly for use in trauma and orthopaedic surgeries.

Market Overview

The gelfoam market is the industry that deals with the manufacture and use of gelfoam, which is a sterile, absorbable gelatin sponge. It is mainly applied in medical and surgical procedures for the control of bleeding, promotion of hemostasis, and aid in tissue repair. It is often used in dental, orthopaedic, neurosurgery, and ENT procedures. Moreover, the global gelfoam market is driven by rising numbers of surgeries, which are increasingly by aging populations and raised healthcare needs. Improvements in medical technology include further advancements in gelfoam formulations while growing awareness of the benefits of such products for hemostasis drives expansion. The growth of healthcare infrastructures in countries in emerging markets and the preference for biodegradable materials that the body assimilates also enhance the demand for gelfoam products in clinical applications. Furthermore, new market opportunities in gelfoam would include creating special products with distinct applications and expansion in minimal access procedures. Growing demand for individualized medicine, increased uptake in emerging economies, and developing technologies in bio-compatible materials could also be mentioned. For instance, Baxter Healthcare Corp. announced this week the FDA approval of the GELFOAM Plus Hemostasis Kit (absorbable gelatin sponge, USP and human thrombin). ELFOAM Plus is the only available hemostasis kit that contains Pfizer's GELFOAM brand plus Baxter's Thrombin (human) for use in controlling bleeding during surgical procedures.

Report Coverage

This research report categorizes the gelfoam market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the gelfoam market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the gelfoam market.

Driving Factors

The demand for gelfoam is driven by increasing emphasis on patient safety and effective recovery in surgeries. As hospitals and healthcare providers focus on minimizing surgical risks, the demand for effective hemostatic solutions like gelfoam increases. In addition, the growing prevalence of chronic diseases worldwide along with the medical research advancements leads to increased adoption of gelfoam for various surgeries. The trend of less invasive surgical procedures also increases demand for such absorbable products.

Restraints & Challenges

The gelfoam market is facing some challenges, including the high cost of medical products, regulatory hurdles, and limited awareness in some regions. Competition from alternative hemostatic materials and concerns over product reactions in certain patients may also restrain market growth.

Market Segmentation

The gelfoam market share is classified into product type and application. 

• The absorbable gelatin sponge segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.

Based on the product type, the gelfoam market is divided into absorbable gelatin sponge, gelatin powder, and gelatin foam. Among these, the absorbable gelatin sponge segment held the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. It is primarily due to the wide applicability of absorbable gelatin sponge in medicine and surgery in the treatment of hemorrhages, promotion of hemostasis. Since it has such efficacy and can easily be applied to be safely absorbed in the body and not be a need for extraction, its applicability makes absorbable gelatin sponge widely demanded, making this product take on a very big share of the market.

• The surgical hemostasis segment accounted for the fastest growth in 2023 and is predicted to grow at a remarkable CAGR during the forecast period.

Based on the application, the gelfoam market is divided into surgical hemostasis, wound care, dental procedures, and others. Among these, the surgical hemostasis segment accounted for the fastest growth in 2023 and is predicted to grow at a remarkable CAGR during the forecast period. The segmental growth due to the overall number of surgeries in the world is rising, especially in trauma care, orthopedic, and neurosurgical procedures where proper control of bleeding is critical. This increases demand for products such as gelfoam, which quickens bleeding control and encourages clotting, making it highly valued among surgeons.

Regional Segment Analysis of the Gelfoam Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the gelfoam market over the predicted timeframe.

North America is anticipated to hold the largest share of the gelfoam market over the predicted timeframe. This is because of the well-developed healthcare infrastructure, high spending on healthcare, and advanced medical technologies in the region. The increasing number of surgeries, along with a strong focus on patient safety and effective hemostasis solutions, drives the demand for gelfoam products. Moreover, the presence of major healthcare providers and manufacturers in the region further supports market growth. For instance, in September 2020, medical device company Merit Medical Systems announced the launch of Torpedo gelatin foam, indicated for the embolization of hypervascular tumors. Torpedo gives physicians pre-shaped gelatin foam loaded into a cartridge with an optional blunt stylet, so they do not have to manually shape the foam and provide fast and easy attachment to the catheter for delivery.

Asia Pacific is expected to grow at a rapid CAGR of the gelfoam market during the forecast period. The growth factors behind this region include expanding health infrastructure, a rising number of surgeries, and access to superior medical technology in places such as China and India. Additionally, the demand for gelfoam products will rise with an increasing aged population and greater awareness regarding surgical safety and wound care solutions in the region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the gelfoam market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Johnson & Johnson
• Pfizer Inc.
• B. Braun Melsungen AG
• Medtronic
• Smith & Nephew
• Stryker Corporation
• Z-Medica LLC
• Integra LifeSciences
• Hemostasis, Inc.
• Fresenius Kabi AG
• Mölnlycke Health Care
• Lepu Medical Technology
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the gelfoam market based on the below-mentioned segments: 

Global Gelfoam Market, By Type

• Absorbable Gelatin Sponge
• Gelatin Powder
• Gelatin Foam

Global Gelfoam Market ,By Application

• Surgical Hemostasis
• Wound Care
• Dental Procedures
• Others

Global Gelfoam Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa